Science | Nature | Cell | View More
Natural Products
Pemetrexed disodium
Pemetrexed disodium
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Pemetrexed disodium
Price:
CAS No.: 150399-23-8
Catalog No.: CFN90017
Molecular Formula: C20H19N5Na2O6
Molecular Weight: 471.37 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Source:
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Download: COA    MSDS
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • University of Minnesota (USA)
  • Centralised Purchases Unit (CPU... (India)
  • Medizinische Universit?t Wien (Austria)
  • University of Dicle (Turkey)
  • Universite Libre de Bruxelles (Belgium)
  • Universitas islam negeri Jakarta (Indonesia)
  • Universiti Sains Malaysia (Malaysia)
  • University of Otago (New Zealand)
  • Heidelberg University (Germany)
  • Julius Kühn-Institut (Germany)
  • Johannes Gutenberg University M... (Germany)
  • More...
Package
Featured Products
Tanshinone IIB

Catalog No: CFN99820
CAS No: 17397-93-2
Price: $463/5mg
Theaflavin

Catalog No: CFN98597
CAS No: 4670-05-7
Price: $268/20mg
Amentoflavone

Catalog No: CFN99526
CAS No: 1617-53-4
Price: $40/20mg
Morroniside

Catalog No: CFN98161
CAS No: 25406-64-8
Price: $50/20mg
Scutellarin

Catalog No: CFN99112
CAS No: 27740-01-8
Price: $30/20mg
Plantamajoside

Catalog No: CFN99522
CAS No: 104777-68-6
Price: $100/20mg
Nicotiflorin

Catalog No: CFN99830
CAS No: 17650-84-9
Price: $80/20mg
Ferruginol

Catalog No: CFN92178
CAS No: 514-62-5
Price: $ / mg
Scutellarein

Catalog No: CFN98557
CAS No: 529-53-3
Price: $60/20mg
Bergapten

Catalog No: CFN98766
CAS No: 484-20-8
Price: $40/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Pemetrexed disodium is a multitargeted antifolate cytotoxic agent mainly used in lung cancer, is an antimetabolite drug, that inhibits enzymes involved in nucleotides bio-synthesis arresting cancer cells cycle. Pemetrexed disodium activates MEK/ERK-dependent cyto-protective autophagy, and inhibition of this pathway potentiates Pemetrexed disodium's activity in HepG2 cells.
Targets: MEK | ERK
In vivo:
Expert Opin Investig Drugs. 2012 Apr;21(4):437-49.
Pemetrexed disodium in ovarian cancer treatment.[Pubmed: 22324304]
Current therapies for recurrent ovarian cancer (OC) yield relatively modest improvements in survival. Many drugs are available but recently a renewed interest is addressed on antimetabolite drugs. Pemetrexed disodium (PEM) is a multitargeted antifolate cytotoxic agent mainly used in lung cancer.
METHODS AND RESULTS:
This review summarizes the available evidence on the use of Pemetrexed disodium in the treatment of OC. This article consists of material obtained via Medline, PubMed and EMBASE literature searches, up to November 2011. Currently available published data on mechanism of action, pharmacokinetics, safety and efficacy of Pemetrexed disodium in the treatment of recurrent OC are described. EXPERT OPINION: Eight trials evaluated the use of Pemetrexed disodium in OC patients. Studies using Pemetrexed disodium in combination with carboplatin in platinum-sensitive OC suggested that the response rate is similar to other combination therapies. However, based on the absence of randomized trials comparing this doublet with currently used combination treatments, it is difficult to draw conclusions on the efficacy of Pemetrexed disodium regimens in these patients.
CONCLUSIONS:
In platinum-resistant OC patients, two studies suggested that Pemetrexed disodium alone might have equivalent activity to other single-agent treatment. Further pharmacogenomic and clinical data are warranted to better define the role of Pemetrexed disodium in the treatment of recurrent OC.
Lung Cancer. 2015 Jun;88(3):319-24.
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.[Pubmed: 25870156 ]
Pemetrexed disodium has been approved for the treatment of advanced non-small cell lung cancer (NSCLC) non-squamous histology, both as first- and second-line therapy. Pemetrexed disodium is an antimetabolite drug, that inhibits enzymes involved in nucleotides bio-synthesis arresting cancer cells cycle. The aim of this study was the evaluation of the impact of Pemetrexed disodium on erythrocyte mean corpuscular volume (MCV) change and its possible correlation with disease control rate (DCR), progression free (PFS) and overall survival (OS) in NSCLC patients.
METHODS AND RESULTS:
A retrospective collection of clinical and laboratory data (including basal MCV and maximum MCV occurred during therapy) in advanced NSCLC patients treated with Pemetrexed disodium at seven Italian centers was performed. Nonparametric tests, univariate and multivariate analysis were used to assess correlation between variables and to identify predictors of outcomes. 191 patients were enrolled: median age 62, 60% male, 61% performance status (PS) 0, 91% stage IV, 88% adenocarcinoma histotype, 25% never smoker, 62% received Pemetrexed disodium as first-line. Mean MCV significantly increased from basal (89fL) to during treatment (94fL), with mean ΔMCV=4fL. The median time from therapy start to maximum MCV was 2.2 months. Median PFS was 7 [CI95% 6-8] and 3 [CI95% 2-4] months [P=0.0016], and median survival was 17 [CI95% 12-23] and 10 [CI95% 8-12] months [P=0.02], in patients with ΔMCV>5fL (n=80) and ΔMCV≤5fL (n=111), respectively. Multivariate analysis identified age ≥62, PS 0, adenocarcinoma histology and ΔMCV>5fL as independent predictors of longer PFS. A ΔMCV>5fL significantly correlates with DCR.
CONCLUSIONS:
Pemetrexed disodium induces macrocytosis. ΔMCV>5fL on Pemetrexed disodium therapy correlated with better DCR, PFS and OS. These results deserve further validation in prospective studies.
Pemetrexed disodium Description
Source:
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Diosniposide B

Catalog No: CFN95333
CAS No: N/A
Price: $413/5mg
Pilosidine

Catalog No: CFN95110
CAS No: 229971-57-7
Price: $413/5mg
Naringin 4'-glucoside

Catalog No: CFN95014
CAS No: 17257-21-5
Price: $338/5mg
8-Epiloganin

Catalog No: CFN95478
CAS No: 79172-04-6
Price: $318/20mg
Methyl lucidenate G

Catalog No: CFN95058
CAS No: 102607-20-5
Price: $413/5mg
N1,N5,N10-(E)-tri-p-coumaroylsperm...

Catalog No: CFN95256
CAS No: 364368-18-3
Price: $388/5mg
Lucidumol A

Catalog No: CFN95059
CAS No: 217476-73-8
Price: $318/5mg
Oxytroflavoside F

Catalog No: CFN95489
CAS No: 1391144-85-6
Price: $318/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.1215 mL 10.6074 mL 21.2148 mL 42.4295 mL 53.0369 mL
5 mM 0.4243 mL 2.1215 mL 4.243 mL 8.4859 mL 10.6074 mL
10 mM 0.2121 mL 1.0607 mL 2.1215 mL 4.243 mL 5.3037 mL
50 mM 0.0424 mL 0.2121 mL 0.4243 mL 0.8486 mL 1.0607 mL
100 mM 0.0212 mL 0.1061 mL 0.2121 mL 0.4243 mL 0.5304 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Cell Research:
Biochem Biophys Res Commun. 2015 Jan 2;456(1):86-91.
Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.[Pubmed: 25446102 ]
Identification of efficient chemo-therapeutic/chemo-preventive agents for treatment of hepatocellular carcinoma (HCC) is important.
METHODS AND RESULTS:
In this study, we examined the activity of pemetrexed, an anti-folate chemotherapy drug, against HepG2 human HCC cells. Pemetrexed disodium treatment in vitro exerted weak but significant cytotoxic activity against HepG2 cells. When analyzing the possible Pemetrexed disodium-resistance factors, we indentified that Pemetrexed disodium treatment in HepG2 cells induced cyto-protective autophagy activation, evidenced by GFP-light chain 3B (LC3B) puncta formation, p62 downregulation and Beclin-1/LC3B-II upregulation. Correspondingly, autophagy inhibitors, including bafliomycin A1, 3-methyladenine and chloroquine, enhanced Pemetrexed disodium-induced cytotoxicity against HepG2 cells. Further, RNAi-mediated knockdown of Beclin-1 in HepG2 cells also increased pemetrexed sensitivity. Pemetrexed disodium activated MEK (mitogen-activated protein kinase/ERK kinase)/ERK (extracellular-signal-regulated kinase) signaling in HepG2 cells, which was required for autophagy induction. Pharmacological inhibition of MEK/ERK activation attenuated Pemetrexed disodium-induced autophagy, enhanced HepG2 cell death and apoptosis.
CONCLUSIONS:
In summary, Pemetrexed disodium activates MEK/ERK-dependent cyto-protective autophagy, and inhibition of this pathway potentiates Pemetrexed disodium's activity in HepG2 cells.
Structure Identification:
Molecules. 2015 May 29;20(6):10004-31.
Synthesis and physicochemical characterization of the impurities of pemetrexed disodium, an anticancer drug.[Pubmed: 26035100]
A physicochemical characterization of the process-related impurities associated with the synthesis of Pemetrexed disodium was performed. The possibility of pemetrexed impurities forming has been mentioned in literature, but no study on their structure has been published yet.
METHODS AND RESULTS:
This paper describes the development of the synthesis methods for these compounds and discusses their structure elucidation on the basis of two-dimensional NMR experiments and MS data. The identification of these impurities should be useful for the quality control during the production of the Pemetrexed disodium salt.
Tanshinone IIB

Catalog No: CFN99820
CAS No: 17397-93-2
Price: $463/5mg
Theaflavin

Catalog No: CFN98597
CAS No: 4670-05-7
Price: $268/20mg
Amentoflavone

Catalog No: CFN99526
CAS No: 1617-53-4
Price: $40/20mg
Morroniside

Catalog No: CFN98161
CAS No: 25406-64-8
Price: $50/20mg
Scutellarin

Catalog No: CFN99112
CAS No: 27740-01-8
Price: $30/20mg
Plantamajoside

Catalog No: CFN99522
CAS No: 104777-68-6
Price: $100/20mg
Nicotiflorin

Catalog No: CFN99830
CAS No: 17650-84-9
Price: $80/20mg
Ferruginol

Catalog No: CFN92178
CAS No: 514-62-5
Price: $ / mg
Scutellarein

Catalog No: CFN98557
CAS No: 529-53-3
Price: $60/20mg
Bergapten

Catalog No: CFN98766
CAS No: 484-20-8
Price: $40/20mg
Tags: buy Pemetrexed disodium | Pemetrexed disodium supplier | purchase Pemetrexed disodium | Pemetrexed disodium cost | Pemetrexed disodium manufacturer | order Pemetrexed disodium | Pemetrexed disodium distributor